D
Satellos Bioscience Inc.
MSCL.TO
TSX
D
Sell
10/23/2024Upgraded
Satellos Bioscience Inc. (MSCL.TO) was upgraded to D- from E+ on 10/23/2024 due to an increase in the volatility index and total return index.
Satellos Bioscience Inc. (MSCL.TO) was upgraded to D- from E+ on 10/23/2024 due to an increase in the volatility index and total return index.
E
Sell
10/8/2024Downgrade
Satellos Bioscience Inc. (MSCL.TO) was downgraded to E+ from D- on 10/8/2024 due to a decline in the volatility index.
Satellos Bioscience Inc. (MSCL.TO) was downgraded to E+ from D- on 10/8/2024 due to a decline in the volatility index.
D
Sell
9/23/2024Upgraded
Satellos Bioscience Inc. (MSCL.TO) was upgraded to D- from E+ on 9/23/2024 due to an increase in the volatility index.
Satellos Bioscience Inc. (MSCL.TO) was upgraded to D- from E+ on 9/23/2024 due to an increase in the volatility index.
E
Sell
9/6/2024Downgrade
Satellos Bioscience Inc. (MSCL.TO) was downgraded to E+ from D- on 9/6/2024 due to a decline in the solvency index, volatility index and growth index. The quick ratio declined from 9.07 to 7.13.
Satellos Bioscience Inc. (MSCL.TO) was downgraded to E+ from D- on 9/6/2024 due to a decline in the solvency index, volatility index and growth index. The quick ratio declined from 9.07 to 7.13.
D
Sell
3/20/2024Upgraded
Satellos Bioscience Inc. (MSCL.TO) was upgraded to D- from E+ on 3/20/2024 due to an increase in the volatility index, total return index and valuation index.
Satellos Bioscience Inc. (MSCL.TO) was upgraded to D- from E+ on 3/20/2024 due to an increase in the volatility index, total return index and valuation index.
E
Sell
3/4/2024Downgrade
Satellos Bioscience Inc. (MSCL.TO) was downgraded to E+ from D- on 3/4/2024 due to a decline in the volatility index and valuation index.
Satellos Bioscience Inc. (MSCL.TO) was downgraded to E+ from D- on 3/4/2024 due to a decline in the volatility index and valuation index.
D
Sell
2/13/2024Upgraded
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 2/13/2024 due to an increase in the volatility index and total return index.
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 2/13/2024 due to an increase in the volatility index and total return index.
E
Sell
1/25/2024Downgrade
Satellos Bioscience Inc. (MSCL.V) was downgraded to E+ from D- on 1/25/2024 due to a decline in the volatility index.
Satellos Bioscience Inc. (MSCL.V) was downgraded to E+ from D- on 1/25/2024 due to a decline in the volatility index.
D
Sell
1/8/2024Upgraded
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 1/8/2024 due to an increase in the volatility index.
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 1/8/2024 due to an increase in the volatility index.
E
Sell
12/12/2023Downgrade
Satellos Bioscience Inc. (MSCL.V) was downgraded to E+ from D- on 12/12/2023 due to a decline in the volatility index and total return index.
Satellos Bioscience Inc. (MSCL.V) was downgraded to E+ from D- on 12/12/2023 due to a decline in the volatility index and total return index.
D
Sell
11/27/2023Upgraded
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 11/27/2023 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0392 to -$0.0236.
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 11/27/2023 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0392 to -$0.0236.
E
Sell
11/10/2023Downgrade
Satellos Bioscience Inc. (MSCL.V) was downgraded to E+ from D- on 11/10/2023 due to a decline in the volatility index, growth index and total return index.
Satellos Bioscience Inc. (MSCL.V) was downgraded to E+ from D- on 11/10/2023 due to a decline in the volatility index, growth index and total return index.
D
Sell
10/26/2023Upgraded
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 10/26/2023 due to an increase in the total return index, volatility index and valuation index.
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 10/26/2023 due to an increase in the total return index, volatility index and valuation index.
E
Sell
9/22/2023Downgrade
Satellos Bioscience Inc. (MSCL.V) was downgraded to E+ from D- on 9/22/2023 due to a decline in the volatility index.
Satellos Bioscience Inc. (MSCL.V) was downgraded to E+ from D- on 9/22/2023 due to a decline in the volatility index.
D
Sell
9/7/2023Upgraded
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 9/7/2023 due to a noticeable increase in the solvency index, total return index and volatility index. The quick ratio increased from 0.99 to 24.74, and debt to equity declined from 0.95 to 0.04.
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 9/7/2023 due to a noticeable increase in the solvency index, total return index and volatility index. The quick ratio increased from 0.99 to 24.74, and debt to equity declined from 0.95 to 0.04.
E
Sell
3/14/2023Downgrade
Satellos Bioscience Inc. (MSCL.TO) was downgraded to E+ from D- on 03/14/2023.
Satellos Bioscience Inc. (MSCL.TO) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
Satellos Bioscience Inc. (MSCL.V) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index and valuation index.
Satellos Bioscience Inc. (MSCL.V) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index and valuation index.
D
Sell
11/25/2022Upgraded
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 11/25/2022 due to a major increase in the growth index, valuation index and volatility index. Earnings per share increased from -$0.0531 to -$0.0417, and EBIT increased 18.64% from -$1.73M to -$1.4M.
Satellos Bioscience Inc. (MSCL.V) was upgraded to D- from E+ on 11/25/2022 due to a major increase in the growth index, valuation index and volatility index. Earnings per share increased from -$0.0531 to -$0.0417, and EBIT increased 18.64% from -$1.73M to -$1.4M.
E
Sell
5/1/2022Upgraded
Satellos Bioscience Inc. (MSCL.V) was upgraded to E+ from E on 5/1/2022 due to an increase in the solvency index.
Satellos Bioscience Inc. (MSCL.V) was upgraded to E+ from E on 5/1/2022 due to an increase in the solvency index.
E
Sell
2/1/2022Upgraded
Satellos Bioscience Inc. (MSCL.V) was upgraded to E from E- on 2/1/2022 due to a significant increase in the solvency index, efficiency index and valuation index. Total capital increased 3,533.87% from -$281.4 to $9.66M, and the quick ratio increased from 0.72 to 3.28.
Satellos Bioscience Inc. (MSCL.V) was upgraded to E from E- on 2/1/2022 due to a significant increase in the solvency index, efficiency index and valuation index. Total capital increased 3,533.87% from -$281.4 to $9.66M, and the quick ratio increased from 0.72 to 3.28.
E
Sell
11/11/2021None
Satellos Bioscience Inc. (MSCL.TO) was downgraded to E- from U on 11/11/2021.
Satellos Bioscience Inc. (MSCL.TO) was downgraded to E- from U on 11/11/2021.
